OBSCN Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-97423APC
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for OBSCN Antibody [Allophycocyanin]
Immunogen
Produced in rabbits immunized with E. coli-derived Human OBSCN fragment.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for OBSCN Antibody [Allophycocyanin]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: OBSCN
Alternate Names
ARHGEF30, DKFZp666E245, EC 2.7.11.1, FLJ14124, KIAA1556MGC120412, KIAA1639MGC138590, MGC120409, MGC120410, MGC120411, obscurin, obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF, obscurin, myosin light chain kinase, Obscurin-MLCK, Obscurin-myosin light chain kinase, Obscurin-RhoGEF, UNC89
Gene Symbol
OBSCN
Additional OBSCN Products
Product Documents for OBSCN Antibody [Allophycocyanin]
Product Specific Notices for OBSCN Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...